Related Experiment Video

Updated: Nov 29, 2025

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation
08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

908

Light control of RTK activity: from technology development to translational research

Anna V Leopold1, Vladislav V Verkhusha1,2

  • 1Medicum , Faculty of Medicine , University of Helsinki , Helsinki 00290 , Finland.

Chemical Science
|November 19, 2020
PubMed

Insights

Optogenetic and optochemical technologies use light to control receptor tyrosine kinases (RTKs) for cancer, diabetes, and neurodegeneration therapies. These light-based methods offer precise, non-invasive control over RTK signaling, overcoming limitations of conventional treatments.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmacology

Background:

  • Receptor tyrosine kinases (RTKs) are crucial in cancer, diabetes, and neurodegeneration.
  • Conventional RTK therapies (inhibitors/activators) lack spatiotemporal control, leading to inefficiency and side effects.

Purpose of the Study:

  • To review optogenetic and optochemical approaches for controlling RTK signaling.
  • To highlight the advantages of light-based RTK modulation over traditional methods.

Main Methods:

  • Optogenetic techniques for light-induced RTK control.
  • Optochemical strategies for precise RTK modulation using light.

Main Results:

  • Light-based methods enable non-invasive, dose-controlled RTK activation or inhibition.
  • These approaches offer high spatio-temporal precision in modulating RTK signaling.
  • Opto-technologies mitigate side effects associated with conventional RTK therapies.

Conclusions:

  • Optogenetic and optochemical RTK technologies represent a significant advancement in therapeutic strategies.
  • These light-controlled methods hold promise for translational studies and future clinical applications.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.2K
Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

9.0K

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
16.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.6K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
83.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.7K